anmelden
SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.09.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.09.21 | Roche Neutral | UBS AG | |
| 07.09.21 | Roche Buy | Jefferies & Company Inc. | |
| 06.09.21 | Novartis Hold | Kepler Cheuvreux | |
| 16.08.21 | Roche Buy | Jefferies & Company Inc. | |
| 09.08.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.08.21 | Roche Outperform | Bernstein Research | |
| 04.08.21 | Novartis Buy | UBS AG | |
| 02.08.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 28.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.07.21 | Novartis Overweight | Morgan Stanley | |
| 23.07.21 | Roche Neutral | Credit Suisse Group | |
| 23.07.21 | Novartis Buy | UBS AG | |
| 22.07.21 | Novartis Hold | Deutsche Bank AG | |
| 22.07.21 | Roche Neutral | UBS AG | |
| 22.07.21 | Novartis Neutral | Credit Suisse Group | |
| 22.07.21 | Roche Buy | Jefferies & Company Inc. | |
| 22.07.21 | Roche Outperform | Bernstein Research | |
| 22.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Market-Perform | Bernstein Research | |
| 21.07.21 | Novartis Market-Perform | Bernstein Research | |
| 21.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Buy | UBS AG | |
| 21.07.21 | Novartis Buy | Jefferies & Company Inc. | |
| 20.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.07.21 | Roche Neutral | UBS AG | |
| 16.07.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 14.07.21 | Roche Buy | Jefferies & Company Inc. | |
| 13.07.21 | Roche Buy | Deutsche Bank AG | |
| 12.07.21 | Novartis Buy | Jefferies & Company Inc. | |
| 12.07.21 | Roche Hold | Jefferies & Company Inc. | |
| 07.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.07.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 30.06.21 | Roche Outperform | Bernstein Research | |
| 29.06.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 28.06.21 | Roche Hold | Deutsche Bank AG | |
| 25.06.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.06.21 | Novartis Hold | Kepler Cheuvreux | |
| 17.06.21 | Roche Hold | Deutsche Bank AG |
